These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38425577)

  • 1. To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis.
    Bertrand D; Deprez A; Doumen M; De Cock D; Pazmino S; Marchal A; Thelissen M; Joly J; De Meyst E; Neerinckx B; Westhovens R; Verschueren P
    Ther Adv Musculoskelet Dis; 2024; 16():1759720X241232268. PubMed ID: 38425577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis.
    Bertrand D; Deprez A; Doumen M; De Cock D; Pazmino S; Marchal A; Thelissen M; Joly J; De Meyst E; Neerinckx B; Westhovens R; Verschueren P
    Musculoskeletal Care; 2024 Jun; 22(2):e1893. PubMed ID: 38693680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping study.
    Roodenrijs NMT; van der Goes MC; Welsing PMJ; van Oorschot EPC; Nikiphorou E; Nijhof NC; Tekstra J; Lafeber FPJG; Jacobs JWG; van Laar JM; Geenen R
    Rheumatology (Oxford); 2021 Nov; 60(11):5105-5116. PubMed ID: 33560301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitions of rheumatoid arthritis flare and how they relate to patients' perspectives: A scoping review of qualitative and quantitative evidence.
    Doumen M; Diricks L; Hermans J; Bertrand D; De Meyst E; Westhovens R; Verschueren P
    Semin Arthritis Rheum; 2024 Aug; 67():152481. PubMed ID: 38815403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration.
    Chatzidionysiou K; Lie E; Lukina G; Hetland ML; Hauge EM; Pavelka K; Gabay C; Scherer A; Nordström D; Canhao H; Santos MJ; Tomsic M; Rotar Z; Hernández MV; Gomez-Reino J; Ancuta I; Kvien TK; van Vollenhoven R
    J Rheumatol; 2017 Feb; 44(2):162-169. PubMed ID: 28089978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatologists' insight into medication adherence in patients with rheumatoid arthritis: A qualitative study.
    Heidari P; Cross W; Weller C; Team V; Nazarinia M; Crawford K
    Int J Rheum Dis; 2019 Sep; 22(9):1695-1705. PubMed ID: 31322831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
    Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
    J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies.
    Vander Cruyssen B; Durez P; Westhovens R; Kaiser MJ; Hoffman I; De Keyser F;
    Arthritis Res Ther; 2010; 12(5):R169. PubMed ID: 20831776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis.
    Kim JW; Jung JY; Shin K; Suh CH; Kim HA
    Front Med (Lausanne); 2021; 8():765535. PubMed ID: 34778324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing rheumatologists' prescription of biological treatment in rheumatoid arthritis: an interview study.
    Kalkan A; Roback K; Hallert E; Carlsson P
    Implement Sci; 2014 Oct; 9():153. PubMed ID: 25304517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis.
    Voshaar MJH; van den Bemt BJF; van de Laar MAFJ; van Dulmen AM; Vriezekolk JE
    BMC Health Serv Res; 2022 Jan; 22(1):62. PubMed ID: 35022034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study.
    Hazlewood GS; Loyola-Sanchez A; Bykerk V; Hull PM; Marshall D; Pham T; Barber CEH; Barnabe C; Sirois A; Pope J; Schieir O; Richards D; Proulx L; Bartlett SJ
    Rheumatology (Oxford); 2022 Feb; 61(2):606-616. PubMed ID: 33878168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study.
    De Cock D; Buckinx E; Pazmino S; Bertrand D; Stouten V; Westhovens R; Verschueren P
    Rheumatol Int; 2022 May; 42(5):815-823. PubMed ID: 34687348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belgian rheumatologists' perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteria.
    Geens E; Geusens P; Vanhoof J; Berghs H; Praet J; Esselens G; Lens S; Dufour JP; Vandenberghe M; Van Mullem X; Westhovens R; Verschueren P
    Rheumatology (Oxford); 2009 May; 48(5):546-50. PubMed ID: 19254920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence rheumatologists' anti-tumor necrosis factor alpha prescribing decisions: a qualitative study.
    Gavan SP; Daker-White G; Payne K; Barton A
    BMC Rheumatol; 2019; 3():47. PubMed ID: 31891115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-management strategies used during flares of rheumatoid arthritis in an ethnically diverse population.
    Kett C; Flint J; Openshaw M; Raza K; Kumar K
    Musculoskeletal Care; 2010 Dec; 8(4):204-14. PubMed ID: 20799370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.
    Gilbert M; Goilav B; Hsu JJ; Nietert PJ; Meidan E; Chua A; Ardoin SP; Wenderfer SE; von Scheven E; Ruth NM;
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):137. PubMed ID: 34461932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysis.
    Kievit W; van Hulst L; van Riel P; Fraenkel L
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):842-7. PubMed ID: 20535795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision Aid-Led Tapering of Biologic and Targeted Synthetic DMARDs in Rheumatoid Arthritis: A Qualitative Study.
    Lee J; Barber C; Jung M; Kaminska E; Bansback N; Richards D; Proulx L; Rebutoc A; Hazlewood GS
    J Rheumatol; 2024 Aug; ():. PubMed ID: 39147416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' and rheumatologists' perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis.
    van Boheemen L; Bolt JW; Ter Wee MM; de Jong HM; van de Sande MG; van Schaardenburg D
    Arthritis Res Ther; 2020 Sep; 22(1):217. PubMed ID: 32933547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.